Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Carrum Health Appoints Randy K. Hawkins, M.D. as Chief Medical Officer
Carrum Health, the first value-based Centers of Excellence (COEs) platform for surgical care, today announced Randy […]
Predictive Health Diagnostics Company Expands Smart Science Diagnostics Platform with Acquisition of MUSE Microscopy Inc.
Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), a diagnostics platform company that develops, manufactures, and […]
Insightful Science Acquires LabArchives to Expand its Electronic Lab Notebook and LIMS Solutions for Scientific Discovery
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
Sandata Announces Emmet O'Gara as New Chief Executive Officer
Sandata is pleased to announce the appointment of Emmet O’Gara as the organization’s next Chief Executive Officer. […]
Dynacure Announces Strategic Collaboration and Option Agreement with Nippon Shinyaku
Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Dutch Stem Cell Biotech Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells® Stem Cell Treatment for Traumatic Spinal Cord Injury
Dutch clinical phase biotech company Neuroplast and Hospital Nacional de Parapléjicos de Toledo in Spain, today […]
Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics
Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]
Booster Bookings Boom As One Million Book Life-Saving Jab in Three Days
More than one million booster jabs have been booked in the last three days as […]
Genoskin Appoints Dr Nicolas Gaudenzio as Chief Scientific Officer
Genoskin, a biotechnology company that provides transformative platforms and tools leveraging live ex vivo human skin to […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more